- Cherokee Inc CHKE shares dipped 31 percent to $5.35 after the company reported a loss for its first quarter on Thursday. The company reported an adjusted loss of $0.07 per share, versus analysts’ estimates for a profit of $0.13 per share.
- ImmunoCellular Therapeutics Ltd IMUC shares fell 22.8 percent to $1.63.
- Kitov Pharmaceuticals Holdings Ltd KTOV shares dropped 20 percent to $1.91 after surging 42.26 percent on Thursday.
- Precipio Inc PRPO shares tumbled 17.7 percent to $13.00.
- RadiSys Corporation RSYS shares dropped 16.7 percent to $3.00 after the company lowered its sales forecast for the second quarter. The company now expects Q2 sales of $35 million, versus earlier outlook of $41 million to $47 million.
- Root9B Holdings Inc RTNB shares fell 14.3 percent to $10.00.
- Dextera Surgical Inc DXTR shares declined 13.2 percent to $0.269 after the company disclosed that it has placed 'temporary shipping hold' on MicroCutter 5/80. The company also reported preliminary FY17 total product sales of $2.9 million to $3 million.
- Ocular Therapeutix Inc OCUL shares declined 11.6 percent to $8.40 after dropping 6.68 percent on Thursday.
- Westport Fuel Systems Inc (USA) WPRT shares slipped 11.3 percent to $1.92.
- Digimarc Corp DMRC dropped 11.2 percent to $34.10. Craig-Hallum downgrades Digimarc from Buy to Hold.
- Oasis Petroleum Inc. OAS shares fell 6.8 percent to $7.20 after declining 3.86 percent on Thursday.
- Nabors Industries Ltd. NBR dropped 6.6 percent to $6.99. Wells Fargo downgraded Nabors Industries from Outperform to Market Perform.
- Oshkosh Corp OSK fell 6 percent to $64.75. Bank of America downgraded Oshkosh from Neutral to Underperform.
- Globant SA GLOB shares declined 4.3 percent to $41.00. KeyBanc downgraded Globant from Overweight to Sector Weight.
- Advaxis, Inc. ADXS dropped 4 percent to $6.43 as the company announced the resignation of its chief executive officer and president Daniel J. O’Connor. The company named Anthony (Tony) Lombardo as interim CEO.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
